Abstract:Menghan Li, 1, 2, * Ran Ding, 3, * Xinming Yang, 1, 2 Dawei Ran 1, 2 1 Acupuncture-Moxibustion Clinical Department, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, 300381, People's Republic of China; 2 Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China; 3 School of Medical Informatics Engineering, Anhui University of Chinese Medicine, Hefei, 230012, People's Republic of China *These authors contributed equally to this work Correspondence: Menghan Li, Email Purpose: PSD is a syndrome that occurs after a stroke, which manifests as a series of depressive symptoms and corresponding physiological symptoms. Relevant studies have shown that the drug therapy is often accompanied by drug side effects and patient resistance. Acupuncture has attracted attention as a treatment method without adverse reactions of patients. The purpose of this study was to investigate the possible mechanism of action of acupuncture in PSD. Patients and Methods: Download depression and stroke datasets from public databases. Bioinformatics methods were used to analyze the key gene targets related to stroke and depression. Functional enrichment analysis assesses important pathways. Further screen PSD-related biological pathways and genes. After the experimental model was established, the expression differences of key genes and related pathways were compared between the model group and the control group through acupuncture treatment and qPCR verification. Results: Depression and stroke-related genes were obtained by bioinformatics methods, and then important biological processes and biological pathways related to depression and stroke were analyzed by GO and KEGG. And further screen out the disease targets closely related to PSD. In the follow-up animal experiments, we confirmed that acupuncture can intervene on these key pathways and targets, and then play a role in the targeted therapy of diseases. Conclusion: The results of this study show that five genes ("NRBP1", "SIRT1", "BDNF", "MAPK3", "CREB1".) and key biological pathways such as NFkB, PI3K/AKT activation, and MAPK are the keys to the occurrence and development of PSD biomarkers, which can also be therapeutically intervened by acupuncture. Keywords: PSD, bioinformation, biomarkers, acupuncture PSD is an affective disorder that occurs after acute cerebrovascular injury. It is one of the most common secondary complications of stroke, which has a significant impact on the quality of life of patients and increases the morbidity and mortality of stroke. 1 Studies have shown that stroke can increase the risk of depression. Thirty-one percent of stroke patients develop depression within 5 years of stroke. Post-stroke depression has become a serious social public health problem. 2 Therefore, exploring the pathogenesis and treatment of PSD is an urgent problem. Acupuncture, as an inexpensive and safe treatment method, has been widely used for thousands of years to improve certain neurological disorders such as stroke and its sequelae. In addition, multiple clinical studies and systematic reviews suggest that acupuncture, 3,4 as a promising intervention, can improve motor and language functions and improve activities of daily living. And there are many studies showing that acupuncture also has the ability to help reorganization, 5 which is helpful for patient recovery. With the growing interest in acupuncture therapy, a lot of research has been done on acupuncture therapy after it was introduced into the scientific community. Acupuncture may become an effective adjunctive therapy or an acceptable alternative therapy for the treatment of functional disorders including post-stroke depression. 6 Related studies have examined 13 cohort studies involving 3536 participants and found that compared with non-PSD patients, PSD patients had significantly higher C-reactive protein levels on admission, proving that C-reactive protein levels were elevated in the acute phase of stroke. Suggest an increased risk of PSD. The discovery of biomarkers has significant implications for the clinical treatment of PSD. 7 The current first-line treatment for PSD is SSRIs, which have some clinical efficacy but cause more cardiovascular and neurological side effects. 8 The debate about SSRIs for the treatment of PSD has focused more on safety, especially in stroke patients who often take multiple drugs at the same time, and the harm tends to be greater. Therefore, -Abstract Truncated-

Pathological Mechanism and Drug Therapy for Post Stroke Depression

Poststroke Depression: A Scientific Statement for Healthcare Professionals from the American Heart Association/American Stroke Association

Systematic Hypothesis for Post-Stroke Depression Caused Inflammation and Neurotransmission and Resultant on Possible Treatments.

Natural Products for the Treatment of Post-stroke Depression

The Efficacy of Therapies for Post-Stroke Depression in Aging: an Umbrella Review.

Prediction of Poststroke Depression Based on the Outcomes of Machine Learning Algorithms

Neural Substrates of Poststroke Depression: Current Opinions and Methodology Trends

Metabolic Alterations and Related Biological Functions of Post-Stroke Depression in Ischemic Stroke Patients

Poststroke depression: psychopharmacological considerations

Management of Poststroke Neuropsychiatric Disorders

Investigating the Potential Mechanisms and Therapeutic Targets of Inflammatory Cytokines in Post-stroke Depression

Study on Biomarkers Related to the Treatment of Post-Stroke Depression and Alternative Medical Treatment Methods

Impact of Baduanjin exercise combined with rational emotive behavior therapy on sleep and mood in patients with poststroke depression: A randomized controlled trial

Post-stroke depression: A 2020 updated review

Post-Stroke Neuropsychiatric Complications: Types, Pathogenesis, and Therapeutic Intervention

Exploring the pathogenesis and treatment of PSD from the perspective of gut microbiota

Preliminary Result of Poststroke Depression: Clinical Characterics and Therapy

Brain‐derived neurotrophic factor and post‐stroke depression

Clinical study of different frequency transcranial magnetic stimulation combined with paroxetine in the treatment of poststroke depression with insomnia

A Chinese Classical Prescription Chaihu Shugan Powder in Treatment of Post-Stroke Depression: An Overview

The infection of clinic psychological care of partients with post-stroke depression